CIK 0001534133 · Non-accelerated filer<br>Smaller reporting company
CalciMedica, Inc.
Sign in to watch- Ticker
- CALC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452120079
- Phone
- 858-952-5500
- Business address
- 505 COAST BOULEVARD SOUTH, SUITE 307, LA JOLLA, CA, 92037
- Former names
- CalciMedica, Inc. /DE/, GRAYBUG VISION, INC., GRAYBUG, Inc., GRAYBUG LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-24 | WILSON ROBERT N Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-06-24 | WILSON ROBERT N Director | Grant or award · Director Stock Option (Right to Buy) | +12,031 | 12,031 | ||
| 2025-06-24 | WILSON ROBERT N Director | Grant or award · Director Stock Option (Right to Buy) | +36,562 | 36,562 | ||
| 2025-06-24 | WILSON ROBERT N Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-06-24 | MIDDLETON FRED A Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-06-24 | MIDDLETON FRED A Director | Grant or award · Director Stock Option (Right to Buy) | +6,562 | 6,562 | ||
| 2025-06-24 | MIDDLETON FRED A Director | Grant or award · Director Stock Option (Right to Buy) | +19,687 | 19,687 | ||
| 2025-06-24 | MIDDLETON FRED A Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-06-11 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +5,000 | $1.85 | $9K | 28,323 |
| 2025-06-06 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +5,000 | $1.78 | $9K | 23,323 |
| 2025-06-05 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +5,100 | $1.70 | $9K | 18,323 |
| 2025-05-30 | Bardin Stephen Chief Financial Officer | Purchase | +1,000 | $1.69 | $2K | 41,000 |
| 2025-04-23 | Bardin Stephen Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2025-04-23 | Stauderman Kenneth A. Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2025-04-23 | Dunn Michael J. President and COO | Grant or award · Employee Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2025-04-23 | Roberts Eric W CHIEF BUSINESS OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2025-04-23 | Hebbar Sudarshan Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2025-04-23 | Leheny A. Rachel CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +285,000 | 285,000 | ||
| 2025-04-05 | Stauderman Kenneth A. Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +65,124 | 65,124 | ||
| 2025-04-05 | Hebbar Sudarshan Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +91,173 | 91,173 |
Page 5 of 29 · 565 trades